Estonia - Sold Production of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale

Since 2014, Estonia Sold Production of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale rose 19.6% year on year. With €2,003,910 in 2019, the country was number 16 among other countries in Sold Production of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale. Denmark lead the ranking with €3,801,340,964.3 in 2019, that is -2.9% versus 2018. Belgium, Italy and Germany respectively ranked number 2, 3 and 4 in this ranking. Italy recorded the best 5 years average growth at +51.7% per year, while Netherlands recorded the worst performance at -13.4% per year.

Loading...

Date Euros
2019 2,003,910.00
2018 1,648,213.00
2017 2,661,503.00
2016 1,751,202.00
2015 1,056,833.00
Download all data from 2000 to 2019

How does Estonia rank in Sold Production of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale?

# 16 Countries Euros Last YoY 5‑years CAGR
1 #1
Denmark
3,801,340,964.30 2019 -2.9 % +26.5 % View data
2 #2
Belgium
1,624,727,500.00 2018 +46.2 % NA View data
15 #15
Macedonia
5,522,929.00 2019 -1.5 % +13.5 % View data
16 #16
Estonia
2,003,910.00 2019 +21.6 % +19.6 % View data
Compare all 16 countries

Go Top